SPDYC: A Potential Drug Target and Biomarker for Diseases (G387778)

Target Name: SPDYC

NCBI ID: G387778

SPDYC

SPDYC: A Potential Drug Target and Biomarker for Diseases

SPDYC (hSpy/Ringo C) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of cell signaling pathways, and is involved in the development and maintenance of tissues.

SPDYC has been identified as a potential drug target due to its involvement in several disease processes, including cancer, neurodegenerative diseases, and autoimmune disorders. It is also a good candidate as a biomarker for certain diseases, as it can be measured and correlated with clinical outcomes.

One of the key functions of SPDYC is its role in the Wnt signaling pathway. This pathway is a well-established regulator of cell proliferation and differentiation, and is involved in the development and maintenance of tissues, including the nervous system and the placenta.

SPDYC is a key component of the Wnt signaling pathway, and its absence or dysfunction has been implicated in the development of several diseases, including cancer. For example, studies have shown that high levels of SPDYC are associated with an increased risk of colorectal cancer, and that inhibition of SPDYC has anti-cancer effects.

In addition to its role in the Wnt pathway, SPDYC is also involved in the development and maintenance of tissues through its role in the TGF-β signaling pathway. This pathway is involved in the regulation of cell growth and differentiation, and is a key regulator of the development of tissues, including muscles, bones, and skin.

SPDYC is also involved in the regulation of cell signaling pathways that are involved in the development and maintenance of tissues. For example, SPDYC is involved in the regulation of the Notch signaling pathway, which is involved in the regulation of stem cells and the development of tissues.

In addition to its role in cell signaling pathways, SPDYC is also involved in the regulation of gene expression. This is important for the development and maintenance of tissues, as genes are responsible for the production of proteins that are involved in the regulation of cell signaling pathways.

SPDYC is a protein that is expressed in various tissues throughout the body, and it is involved in the development and maintenance of tissues through its role in several cell signaling pathways. Its absence or dysfunction has been implicated in the development of several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, SPDYC is a potential drug target and a good candidate as a biomarker for certain diseases.

Protein Name: Speedy/RINGO Cell Cycle Regulator Family Member C

Functions: Promotes progression through the cell cycle via binding and activation of CDK1 and CDK2. Involved in the spindle-assembly checkpoint. Required for recruitment of MAD2L1, BUBR1 and BUB1 to kinetochores. Required for the correct localization of the active form of Aurora B in prometaphase

The "SPDYC Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SPDYC comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets